atherosclerosis, cardiovascular disease, primary prevention, low to moderate risk patients, older patients
DISEASE INTERVENTION COMPARISON RESULTS
JAMA Intern Med. 2017 Jul 01;177(7):955-965 Randomized Controlled Trial, Multicenter Study
IN atherosclerosis, cardiovascular disease, primary prevention, low to moderate risk patients, older patients The Use of
statin, pravastatin, 40 mg/d
As Prevention, Primary
Is equal Than
usual care
To modify, after 6 years, mortality or coronary disease